Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Microbes and Infection|July 26, 2008
Gene-expression profiles in murine melioidosisW Joost Wiersinga, Mark C Dessing, Tom van der PollCellular Microbiology|August 23, 2007
Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococciMark C Dessing, Sandrine Florquin, James C Paton, et al.BMJ Public Health|March 6, 2026
Influence of lifestyle factors on susceptibility, disease course and recovery from post COVID-19 syndrome: a scoping reviewW Marty Blom, Mark C Dessing, Suzan Wopereis, et al.Infection and Immunity|September 20, 2006
Monocyte chemoattractant protein 1 does not contribute to protective immunity against pneumococcal pneumoniaMark C Dessing, Alex F de Vos, Sandrine Florquin, et al.Immunology Letters|September 11, 2007
CD14 plays a limited role during influenza A virus infection in vivoMark C Dessing, Koenraad F van der Sluijs, Sandrine Florquin, et al.Clinical Immunology (Orlando, Fla.)|September 11, 2007
Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumoniaMark C Dessing, Koenraad F van der Sluijs, Sandrine Florquin, et al.Plos One|December 4, 2009
Role of Toll-like receptors 2 and 4 in pulmonary inflammation and injury induced by pneumolysin in miceMark C Dessing, Robert A Hirst, Alex F de Vos, et al.Pharmacology & Therapeutics|March 2, 2017
TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectivesAlessandra Tammaro, Marc Derive, Sebastien Gibot, et al.Scientific Reports|November 8, 2016
Donor and recipient genetic variants in NLRP3 associate with early acute rejection following kidney transplantationMark C Dessing, Jesper Kers, Jeffrey Damman, et al.Journal of Innate Immunity|April 9, 2010
Gene expression profiles in murine influenza pneumoniaMark C Dessing, Koenraad F van der Sluijs, C Arnold Spek, et al.Pageof 5